Crossref
Noninvasive PET imaging of tumor PD-L1 expression with 64Cu-labeled Durvalumab
American Journal of Nuclear Medicine and Molecular Imaging · 2024
DOI: 10.62347/huqd8000 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Nuclear Medicine and Molecular Imaging, 2024. Verfasst von Sara Malih. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 67 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Malih, S. (2024). Noninvasive PET imaging of tumor PD-L1 expression with 64Cu-labeled Durvalumab. American Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.62347/huqd8000
Vancouver
Malih S. Noninvasive PET imaging of tumor PD-L1 expression with 64Cu-labeled Durvalumab. American Journal of Nuclear Medicine and Molecular Imaging. 2024. doi:10.62347/huqd8000
BibTeX
@article{Malih2024,
author = {Malih, Sara},
title = {Noninvasive PET imaging of tumor PD-L1 expression with 64Cu-labeled Durvalumab},
journal = {American Journal of Nuclear Medicine and Molecular Imaging},
year = {2024},
doi = {10.62347/huqd8000}
}
EUVIMED